Home
ADAG
ADAG News

Latest Adagene Inc. (ADAG) News on November 14, 2025

Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

GlobeNewswire

a day ago

Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

AC Immune And 2 Other Promising Penny Stocks

Simply Wall St.

14 days ago

AC Immune And 2 Other Promising Penny Stocks

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

GlobeNewswire

15 days ago

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China

GlobeNewswire

2 months ago

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China

Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Zacks

5 months ago

Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Adagene to Present at Jefferies Global Healthcare Conference 2025

GlobeNewswire

6 months ago

Adagene to Present at Jefferies Global Healthcare Conference 2025

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

6 months ago

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting

Smart Share Global And 2 Other Compelling Penny Stocks To Watch

Simply Wall St.

6 months ago

Smart Share Global And 2 Other Compelling Penny Stocks To Watch

Adagene Appoints John Maraganore, Ph.D. as Executive Advisor

GlobeNewswire

7 months ago

Adagene Appoints John Maraganore, Ph.D. as Executive Advisor

Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

7 months ago

Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting

Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum

GlobeNewswire

7 months ago

Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum

Adagene And 2 Other Promising Penny Stocks To Watch

Simply Wall St.

7 months ago

Adagene And 2 Other Promising Penny Stocks To Watch

Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update

Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit

GlobeNewswire

8 months ago

Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit

Adagene to Present at Leerink’s Global Healthcare Conference 2025

GlobeNewswire

8 months ago

Adagene to Present at Leerink’s Global Healthcare Conference 2025

Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer

GlobeNewswire

9 months ago

Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

GlobeNewswire

10 months ago

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

GlobeNewswire

10 months ago

Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody® ADG126 in Advanced/Metastatic Microsatellite-Stable (MSS) Colorectal Cancer (CRC) on January 25, 2025

GlobeNewswire

10 months ago

Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody® ADG126 in Advanced/Metastatic Microsatellite-Stable (MSS) Colorectal Cancer (CRC) on January 25, 2025

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

10 months ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?

Zacks

a year ago

Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Adagene (ADAG) This Year?

November 2024's Top Picks: Penny Stocks On US Exchanges

Simply Wall St.

a year ago

November 2024's Top Picks: Penny Stocks On US Exchanges

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire

a year ago

Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Adagene And 2 Other US Penny Stocks To Consider

Simply Wall St.

a year ago

Adagene And 2 Other US Penny Stocks To Consider

Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire

a year ago

Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

GlobeNewswire

a year ago

Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Adagene to Participate in Investor Conferences in September

GlobeNewswire

a year ago

Adagene to Participate in Investor Conferences in September

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Is MannKind (MNKD) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is MannKind (MNKD) Stock Outpacing Its Medical Peers This Year?

Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)

Simply Wall St.

a year ago

Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)

Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update

GlobeNewswire

a year ago

Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September

GlobeNewswire

a year ago

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September

Adagene Inc. (NASDAQ:ADAG) most popular amongst private equity firms who own 39% of the shares, institutions hold 30%

Simply Wall St.

a year ago

Adagene Inc. (NASDAQ:ADAG) most popular amongst private equity firms who own 39% of the shares, institutions hold 30%

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

a year ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

a year ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Where Will DocuSign Stock Be in 1 Year?

Motley Fool

a year ago

Where Will DocuSign Stock Be in 1 Year?

**Canadian Interest in American Whiskey Peaks Ahead of Bourbon Day**

CNW Group

a year ago

Canadian Interest in American Whiskey Peaks Ahead of Bourbon Day

Poppulo Joins Elite Category in BrightSign Bright Alliance Program, Announces Certification Across Series 5 Devices

GlobeNewswire

a year ago

Poppulo Joins Elite Category in BrightSign Bright Alliance Program, Announces Certification Across Series 5 Devices

Spotify to introduce expensive plan later this year, Bloomberg News reports

Reuters

a year ago

Spotify to introduce expensive plan later this year, Bloomberg News reports

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

a year ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

a year ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Adagene to Present at Investor Conferences in June

GlobeNewswire

a year ago

Adagene to Present at Investor Conferences in June

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

GlobeNewswire

2 years ago

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024

GlobeNewswire

2 years ago

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024

Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

GlobeNewswire

2 years ago

Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC

GuruFocus.com

2 years ago

Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC

Marine Products (NYSE:MPX) Will Pay A Dividend Of $0.14

Simply Wall St.

2 years ago

Marine Products (NYSE:MPX) Will Pay A Dividend Of $0.14

Several Headwinds Dragged GrafTech International Ltd. (EAF)

Insider Monkey

2 years ago

Several Headwinds Dragged GrafTech International Ltd. (EAF)

Fenner Gap and Victor Valley Water Agencies Launch "One Water" Plan

PR Newswire

2 years ago

Fenner Gap and Victor Valley Water Agencies Launch "One Water" Plan

West Bancorporation, Inc. Announces Fourth Quarter and Year End 2023 Financial Results and Declares Quarterly Dividend

GlobeNewswire

2 years ago

West Bancorporation, Inc. Announces Fourth Quarter and Year End 2023 Financial Results and Declares Quarterly Dividend

Alimera Sciences (NASDAQ:ALIM) shareholders have endured a 69% loss from investing in the stock five years ago

Simply Wall St.

2 years ago

Alimera Sciences (NASDAQ:ALIM) shareholders have endured a 69% loss from investing in the stock five years ago

American Vanguard Scheduled to Announce Preliminary Unaudited Q4 & Full Year 2023 Financial Highlights

Business Wire

2 years ago

American Vanguard Scheduled to Announce Preliminary Unaudited Q4 & Full Year 2023 Financial Highlights

Q3 Earnings Roundup: Magnachip (NYSE:MX) And The Rest Of The Analog Semiconductors Segment

StockStory

2 years ago

Q3 Earnings Roundup: Magnachip (NYSE:MX) And The Rest Of The Analog Semiconductors Segment

Footwear News

2 years ago

Exclusive: Designer Brands Inc. Taps Andrea O’Donnell As Brands President

Designer Brands Inc. Names Andrea O'Donnell in Role of Brands President

PR Newswire

2 years ago

Designer Brands Inc. Names Andrea O'Donnell in Role of Brands President

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

GlobeNewswire

2 years ago

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

Cadiz Insiders Placed Bullish Bets Worth US$547.1k

Simply Wall St.

2 years ago

Cadiz Insiders Placed Bullish Bets Worth US$547.1k

Trinseo Announces Release Date and Conference Call for its Fourth Quarter and Full Year 2023 Financial Results

Business Wire

2 years ago

Trinseo Announces Release Date and Conference Call for its Fourth Quarter and Full Year 2023 Financial Results

One Energy Launches "Just Roll" Electric Semi-Truck Trial Program

Business Wire

2 years ago

One Energy Launches "Just Roll" Electric Semi-Truck Trial Program

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

GlobeNewswire

2 years ago

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

PR Newswire

2 years ago

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?

Zacks

2 years ago

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?

ESS Technology to Demonstrate Value of Long-Duration Energy Storage in Military Applications

Business Wire

2 years ago

ESS Technology to Demonstrate Value of Long-Duration Energy Storage in Military Applications

The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable

Simply Wall St.

2 years ago

The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable

7 Small-Cap Stocks With Huge Potential Flying Under the Radar

InvestorPlace

2 years ago

7 Small-Cap Stocks With Huge Potential Flying Under the Radar

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

GlobeNewswire

2 years ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

Mondee to Participate in 26th Annual Needham Growth Conference

GlobeNewswire

2 years ago

Mondee to Participate in 26th Annual Needham Growth Conference

Adagene Inc.'s (NASDAQ:ADAG) market cap surged US$34m last week, retail investors who have a lot riding on the company were rewarded

Simply Wall St.

2 years ago

Adagene Inc.'s (NASDAQ:ADAG) market cap surged US$34m last week, retail investors who have a lot riding on the company were rewarded

Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024

Business Wire

2 years ago

Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024

Does American Vanguard Corporation (AVD) Offer a Valuable Investment Opportunity?

Insider Monkey

2 years ago

Does American Vanguard Corporation (AVD) Offer a Valuable Investment Opportunity?

Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases

GlobeNewswire

2 years ago

Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases

Shoe Carnival Inc's Dividend Analysis

GuruFocus.com

2 years ago

Shoe Carnival Inc's Dividend Analysis

Forum Energy Technologies Completes Acquisition of Variperm Energy Services

Business Wire

2 years ago

Forum Energy Technologies Completes Acquisition of Variperm Energy Services

Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

2 years ago

Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Voyager Therapeutics Announces Proposed Public Offering

GlobeNewswire

2 years ago

Voyager Therapeutics Announces Proposed Public Offering

Bank7 (BSVN) Moves to Buy: Rationale Behind the Upgrade

Zacks

2 years ago

Bank7 (BSVN) Moves to Buy: Rationale Behind the Upgrade

Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium

GlobeNewswire

2 years ago

Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium

Gevo Announces Appointment of Katie Ellet to Board of Directors

GlobeNewswire

2 years ago

Gevo Announces Appointment of Katie Ellet to Board of Directors

71st Scripps Howard Awards accepting entries Jan. 3-Feb. 5

PR Newswire

2 years ago

71st Scripps Howard Awards accepting entries Jan. 3-Feb. 5

Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vishay Precision Group, Inc. (NYSE:VPG) is favoured by institutional owners who hold 87% of the company

Simply Wall St.

2 years ago

Vishay Precision Group, Inc. (NYSE:VPG) is favoured by institutional owners who hold 87% of the company

Following Unanimous Ruling from Superior Court of Peru Confirming Company’s Title to 32 Disputed Concessions, INGEMMET and MINEM Petition the Supreme Court in a Final Attempt to Reverse the Ruling

GlobeNewswire

2 years ago

Following Unanimous Ruling from Superior Court of Peru Confirming Company’s Title to 32 Disputed Concessions, INGEMMET and MINEM Petition the Supreme Court in a Final Attempt to Reverse the Ruling

Estimating The Fair Value Of Nukkleus Inc. (NASDAQ:NUKK)

Simply Wall St.

2 years ago

Estimating The Fair Value Of Nukkleus Inc. (NASDAQ:NUKK)

Are Investors Undervaluing Galiano Gold (GAU) Right Now?

Zacks

2 years ago

Are Investors Undervaluing Galiano Gold (GAU) Right Now?

DouYu International Holdings Limited Announces Share Repurchase Program

PR Newswire

2 years ago

DouYu International Holdings Limited Announces Share Repurchase Program

Why You Might Be Interested In Parke Bancorp, Inc. (NASDAQ:PKBK) For Its Upcoming Dividend

Simply Wall St.

2 years ago

Why You Might Be Interested In Parke Bancorp, Inc. (NASDAQ:PKBK) For Its Upcoming Dividend

Share on Social Networks: